The newly released software algorithm is designed to address and treat heart failure patients who are not responsive to other pacing options, and can automatically adjust pacing based on real-time changes in cardiac condition.
“Although we have made substantial improvements in how we treat heart failure patients, there are still certain patients who are not getting the outcomes with traditional CRT that we would like to see. The SyncAV CRT algorithm dynamically individualizes programming to work towards providing patients with the right settings at the right time helping offer the best possible outcome for even our most complex patients. Our goal is to utilize the technology to improve outcomes while offering patients who do not respond to therapy with additional options for treatment,” Dr. Timothy Bett of the John Radcliffe Hospital said in a prepared statement.
The St. Paul, Minn.-based company said it also received CE Mark approval for the Quadra Assura MP CRT-Defibrillator with full-body magnetic resonance imaging labeling, giving patients wit the device access to MRI diagnostic testing.
Last week, St. Jude announced the European launch of its Infinity deep brain stimulation system and direction DBS lead, designed to support treatments for movement disorders.
The Infinity DBS system won CE Mark approval in the European Union last September.
St. Jude said the Infinity system is designed so that Apple (NSDQ:AAPL) mobile devices can be used as wireless controllers, via a Bluetooth connection, and that it’s the only upgradable DBS system for movement disorders including Parkinson’s disease, tremor and dystonia.
The directional leads are designed to allow doctors to “steer” current to different parts of the brain, tailoring treatment to reduce side effects, St. Jude said.
The post St. Jude wins CE Mark, launches SyncAV CRT algorithm appeared first on MassDevice.
from MassDevice http://ift.tt/28Zi5sf
Cap comentari:
Publica un comentari a l'entrada